This study delivers structurally refined dihydrothiazolyl hydrazone hybrids, leveraging coordinated synthetic design, SAR guidance, and molecular modeling to achieve precise dual-site modulation of acetylcholinesterase enzyme for the treatment of Alzheimer's disease. Here, ACHE is linked to Alzheimer disease.